Unrestricted Grant

A tumor suppressor mouse model of glioblastoma

Principal Investigator: Luis F. Parada, PhD

Institute: University of Texas Southwestern Medical Center

Initiative: Unrestricted Grant

Location: Dallas, TX

AACR-NBTS Career Development Award for Translational Brain Tumor Research

Principal Investigator: Markus D. Siegelin, MD

Institute: Columbia University Medical Center

Initiative: Unrestricted Grant

Location: Manhattan, NY

AANS 2009 Translational Research Grant: Promoter methylations in GBM a paradigm beyond methylguanine-DNA MGMT

Principal Investigator: Clark Chen, MD, PhD

Institute: Dana-Farber Cancer Institute

Initiative: Unrestricted Grant

Location: Boston, MA

AANS/CNS Translational Award: The colony-forming antibody cell array: A novel screening strategy to further identify cancer stem cells in human malignant gliomas

Principal Investigator: Stephen Skirboll, MD

Institute: Stanford University

Initiative: Unrestricted Grant

Location: Stanford, CA

Active specific immunotherapy of glioma

Principal Investigator: Dorothee Herlyn, DVM

Institute: The Wistar Institute

Initiative: Unrestricted Grant

Location: Philadelphia, PA

Allelic variation in carcinogen metabolism and brain tumor risk

Principal Investigator: Karl Kelsey, MD, MOH

Institute: Harvard University

Initiative: Unrestricted Grant

Location: Boston, MA

Analysis of acrylonitile and ethylene oxide mutagenesis and neurooncogenesis via mutational spectra and DNA transfections

Principal Investigator: Vernon E. Walker, DVM, PhD

Institute: Lovelace Respiratory Research Institute

Initiative: Unrestricted Grant

Location: Albuquerque, NM

Analysis of the mismatch repair pathway in chemoresistant human glioblastomas

Principal Investigator: David N. Louis, MD

Institute: Massachusetts General Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Anti-HGF Monoclonal Antibody Therapy for Malignant Glioma

Principal Investigator: John Laterra, MD, PhD

Institute: Kennedy Krieger Inst.

Initiative: Unrestricted Grant

Location: Baltimore, MD

Antiangiogenetic immunotherapy of malignant brain tumors

Principal Investigator: John H. Sampson, MD, PhD

Institute: Duke University Medical Center

Initiative: Unrestricted Grant

Location: Durham, NC

Applications of lipid-coated midrobubble ultrasonic contrast to the therapy of brain tumors

Principal Investigator: Richard Simon, MD

Institute: University of Connecticut

Initiative: Unrestricted Grant

Location: Farmington, CT

Are neural stem cells a source of brain tumors?

Principal Investigator: Arturo Alvarez-Buylla, PhD

Institute: University of California, San Francisco

Initiative: Unrestricted Grant

Location: San Francisco, CA

Cell to cell signaling and control growth and differentiation in brain

Principal Investigator: Achim Gossler, PhD

Institute: Institute for Molecular Biology, Medizinische Hochschule Hannover

Initiative: Unrestricted Grant

Location: Hanover, Lower Saxony

Critical role of NF-xB activation in necrosis formation in human glioblastoma

Principal Investigator: Suyun Huang, MD, PhD

Institute: MD Anderson Cancer Center

Initiative: Unrestricted Grant

Location: Chicago, IL

DCC tumor suppressor gene-expression and function in gliomas

Principal Investigator: Michael A. Reale, MD, PhD

Institute: Yale School of Medicine

Initiative: Unrestricted Grant

Location: New Haven, CT

Defining microRNA signaling in malignant gliomas

Principal Investigator: Anna Krichevsky, PhD

Institute: Brigham and Women’s Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Defining the basis of enhanced CXCR4 signaling in brain tumors

Principal Investigator: Joshua B Rubin, MD, PhD

Initiative: Unrestricted Grant

Institute: Washington University School of Medicine

Location: St. Louis, MO

Defining the Role of Foxo Transcription Factors and Sirt1 Deacetylase in Suppressing Glioblastomas

Principal Investigator: Anne Brunet, PhD

Institute: Stanford University

Initiative: Unrestricted Grant

Location: Stanford, CA

Defining the role of p53 in the suppression of glioblastoma

Principal Investigator: Gerard Evan, PhD

Institute: University of California, San Francisco

Initiative: Unrestricted Grant

Location: San Francisco, CA

Dendritic cell and dexosome interaction with glioblastoma multiforme

Principal Investigator: Evan M. Hersh, MD

Institute: University of Arizona

Initiative: Unrestricted Grant

Location: Tucson, AZ

Dendritic cells, oncolytic hsv, and brain tumor immunotherapy

Principal Investigator: Samuel D. Rabkin, PhD

Institute: Massachusetts General Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Determining the Natural History of Immunological Response in GBM Patients

Principal Investigator: Amy B Heimberger, MD

Institute: MD Anderson Cancer Center

Initiative: Unrestricted Grant

Location: Houston, TX

Effects of the suppressive CNS micro-environment on tumor growth in the brain

Principal Investigator: Paul M. Knopf, PhD

Institute: Brown University

Initiative: Unrestricted Grant

Location: Barrington, RI

Enhancement of radiosurgical effects on brain tumors using neural stem cell-based gene expression

Principal Investigator: Ajay Niranjan, MBBS, MS, MCh

Institute: University of Pittsburgh

Initiative: Unrestricted Grant

Location: Pittsburgh, PA

Enhancing survival and function of glioma-specific T-cells in the tumor microenvironment

Principal Investigator: Michael C. Jensen, MD, PhD

Institute: City of Hope National Medical Center

Initiative: Unrestricted Grant

Location: Duarte, CA

Evolution of a hypomethylator phenotype in glioblastoma

Principal Investigator: Joseph Costello, PhD

Institute: University of California, San Francisco

Initiative: Unrestricted Grant

Location: San Francisco, CA

Expression and function of neurotrophins in medulloblastoma

Principal Investigator: Scott L. Pomeroy, MD, PhD

Institute: Children’s Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Feasibility of T cell immunotherapy for glioblastoma multiforme

Principal Investigator: Lawrence A. Lamb, PhD

Institute: University of Alabama, Birmingham

Initiative: Unrestricted Grant

Location: Birmingham, AL

Functional genomics analysis of primitive neuroectodermal tumors

Principal Investigator: Paul M. Knoepfler, PhD

Institute: University of California, Davis

Initiative: Unrestricted Grant

Location: Davis, CA

Functions of transforming growth factor-and the epidermal growth factor receptor in the development of glioblastomas

Principal Investigator: Emmett V. Schmidt, MD, PhD

Institute: Massachusetts General Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Generation and characterization of conditional cancer mouse models for atypical teratoid/rhabdoid tumor and choid plexus carcinoma

Principal Investigator: Tom Curran, PhD, FRS

Institute: Children’s Hospital of Philadelphia

Initiative: Unrestricted Grant

Location: Philadelphia, PA

Genetic Approaches to New Therapeutic Targets in Brain Cancer

Principal Investigator: Gregory Hannon, PhD

Institute: Cold Spring Harbor Laboratory

Initiative: Unrestricted Grant

Location: Cold Spring Harbor, NY

Genetic targeting of cerebellar stem cells to study development and tumorigenesis

Principal Investigator: Robert Wechsler-Reya, PhD

Institute: Sanford-Burnham Medical Research Institute

Initiative: Unrestricted Grant

Location: La Jolla, CA

Genetically engineered anti-angiogenic anti-tumor cytotoxic lymphocytes: A novel immunotherapeutic strategy for malignant glioma

Principal Investigator: Richard C. Mulligan, PhD

Institute: Children’s Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Genetically engineered anti-glioma CTL’s in a murine model of EGFRvIII expressing tumors

Principal Investigator: Bob S. Carter, MD, PhD

Institute: Massachusetts General Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Genetically engineered cells designed to deliver drugs by apoptosis

Principal Investigator: James M. Gallo, PhD

Institute: Fox Chase Cancer Center

Initiative: Unrestricted Grant

Location: Philadelphia, PA

Glioblastoma Multiforme: A model for cellular radioresistance

Principal Investigator: Myles Astor, PhD

Institute: New York Medical College

Initiative: Unrestricted Grant

Location: Valhalla, NY

Glioma cancer stem cells in tumor angiogenesis

Principal Investigator: Jeremy Rich, MD

Institute: Cleveland Clinic

Initiative: Unrestricted Grant

Location: Cleveland, OH

Glioma rejection by natural killer cells and IL-10 producing CD4+ T cells

Principal Investigator: Benjamin Matthew Segal, MD

Institute: University of Rochester

Initiative: Unrestricted Grant

Location: Rochester, NY

Glutamate receptor antagonists in malignant gliomas

Principal Investigator: Maiken Nedergaard, MD, PhD

Institute: University of Rochester

Initiative: Unrestricted Grant

Location: Rochester, NY

GM3 as a novel apoptosis inducing agent for human gliomas

Principal Investigator: Peter McL. Black, MD, PhD

Institute: Brigham and Women’s Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Gorlin syndrome gene in medulloblastoma

Principal Investigator: Allen Bale, MD

Institute: Yale University

Initiative: Unrestricted Grant

Location: New Haven, CT

Harnessing Apoptosis for Medulloblastoma Therapy

Principal Investigator: Vidya Gopalakrishnan, PhD

Institute: MD Anderson Cancer Center

Initiative: Unrestricted Grant

Location: Houston, TX

Hedgehog pathway in medulloblastoma

Principal Investigator: Allen Bale, MD

Institute: Yale University

Initiative: Unrestricted Grant

Location: New Haven, CT

Identification and characterization of novel substrates of neuronal receptor tyrosine kinases

Principal Investigator: David D. Ginty, PhD

Institute: Johns Hopkins Hospital

Initiative: Unrestricted Grant

Location: Baltimore, MD

Identification and cloning of genes correlating with human astrocytic tumor progression using PCR based differential display of mRNA

Principal Investigator: Peter McL. Black, MD, PhD

Institute: Brigham and Women’s Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Identification and immunologic targeting of HCMV antigens expressed in malignant gliomas

Principal Investigator: Duane Mitchell, MD, PhD

Institute: Duke University Department of Surgery

Initiative: Unrestricted Grant

Location: Durham, NC

Identification of a gene on chromosome 22 involved in the genesis of embryonal brain tumors

Principal Investigator: Deborah E. Schofield, MD

Institute: Children’s Hospital

Initiative: Unrestricted Grant

Location: Hollywood, CA

Identification of genes involved in gliomagenesis of INK4a null mice, Role of the PTEN tumor suppressor in the progression of glioma

Principal Investigator: Ming-Jian You, MD, PhD

Institute: Dana-Farber Cancer Institute

Initiative: Unrestricted Grant

Location: Boston, MA

Identification of genes regulating glial cell behavior in the developing visual system of drosophilia

Principal Investigator: Ulrike Gaul, PhD

Institute: Rockefeller University

Initiative: Unrestricted Grant

Location: Manhattan, NY

Identification of Key Genetic and Growth Control Pathway Changes in JPA that Represent Potential Molecular Targets for Therapuetic Intervention

Principal Investigator: Tobey MacDonald, MD

Institute: Children’s National Medical Center

Initiative: Unrestricted Grant

Location: Washington, DC

Identification of molecular and cellular targets of malignant astrocytoma in a mouse model

Principal Investigator: Yuan Zhu, PhD

Institute: University of Michigan Medical School

Initiative: Unrestricted Grant

Location: Ann Arbor, MI

Identification of novel molecules that function in the PTEN/PI 3-kinase regulated signaling pathway in human glioblastoma cells

Principal Investigator: Hong Sun, PhD

Institute: Yale University

Initiative: Unrestricted Grant

Location: New Haven, CT

Identification of the chromosome 19q glioma tumor suppressor gene

Principal Investigator: David N. Louis, MD

Institute: Massachusetts General Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Identifying and overcoming resistance in GBM

Principal Investigator: Minesh Mehta, MD

Institute: American College of Radiology, Radiation Therapy Oncology Group

Initiative: Unrestricted Grant

Location: Philadelphia, PA

Immunotherapy of Malignant Gliomas Using Cytokine-Producing delta gamma-1 34.5 HSV

Principal Investigator: Jacqueline N. Parker, PhD

Institute: University of Alabama, Birmingham

Initiative: Unrestricted Grant

Location: Birmingham, AL

Immunotherapy of Pediatric Brain Tumors (Dendritic cell-GBM fusion cell vaccines)

Principal Investigator: Gregory Plautz, MD

Institute: Cleveland Clinic

Initiative: Unrestricted Grant

Location: Cleveland, OH

Inhibition of Regulatory T cell Recovery with an IL-2 Receptor Blocking Antibody

Principal Investigator: John H. Sampson, M.D., PhD

Institute: Duke University

Initiative: Unrestricted Grant

Location: Durham, NC

Investigation of the mechanisms underlying chemoresistance of glioblastoma multiforme to platinum treatment

Principal Investigator: Zhimin Lu, MD, PhD

Institute: MD Anderson Cancer Center

Initiative: Unrestricted Grant

Location: Houston, TX

Jun- and MEF2-mediated apoptosis in medulloblastoma

Principal Investigator: John Y.H. Kim, MD, PhD

Institute: Baylor College of Medicine

Initiative: Unrestricted Grant

Location: Houston, TX

Kinase inhibitor therapy using a switchable allele of EGFR

Principal Investigator: William A. Weiss, MD, PhD

Institute: University of California, Irvine

Initiative: Unrestricted Grant

Location: Irvine, CA

Lysosome-directed drug delivery for binary therapy of brain tumors

Principal Investigator: Takeshi Sano, PhD

Institute: Beth Israel Deaconess Medical Center

Initiative: Unrestricted Grant

Location: Boston, MA

Mechanisms related to the bystander cytocidal effect and the role of the bystander effect in the treatment of meningeal neoplasms

Principal Investigator: Frank D. Vrionis, MD, PhD

Institute: New England Medical Center

Initiative: Unrestricted Grant

Location: Boston, MA

Mitogenic effect of sonic hedgehog in the CNS of transgenic mice

Principal Investigator: David H. Rowitch, MD, PhD

Institute: Dana-Farber Cancer Institute

Initiative: Unrestricted Grant

Location: Boston, MA

Mitotic Olig2+ in glioma formation

Principal Investigator: Qing Richard Lu, PhD

Institute: University of Texas-Southwestern University

Initiative: Unrestricted Grant

Location: Dallas, TX

Modeling progression from low grade astrocytoma to GBM in genetically engineered mice

Principal Investigator: Terry A. Van Dyke, PhD ME

Institute: University of North Carolina at Chapel Hill

Initiative: Unrestricted Grant

Location: Chapel Hill, NC

Modulation of phosphoinositide-3-Oh kinase (P13-K) activation and glioma phenotype by signaling regulatory proteins

Principal Investigator: Donald M. O’Rourke, MD

Institute: University of Pennsylvania

Initiative: Unrestricted Grant

Location: Philadelphia, PA

Molecular analysis of the SynCAM family of tumor suppressors in the brain

Principal Investigator: Thomas Biederer, PhD

Institute: Yale University

Initiative: Unrestricted Grant

Location: New Haven, CT

Molecular genetics of human brain tumors

Principal Investigator: Elizabeth W. Newcomb, PhD

Institute: New York University Medical Center

Initiative: Unrestricted Grant

Location: Manhattan, NY

Molecular mechanisms of Human Glioma Angiogenesis

Principal Investigator: Shi-Yuan Cheng, PhD

Institute: University of Pittsburgh

Initiative: Unrestricted Grant

Location: Pittsburgh, PA

Molecular predictors of chemotherapeutic response and survival in oligodendroglial tumors

Principal Investigator: David N. Louis, MD

Institute: Massachusetts General Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Molecular targeting of GBM with oncolytic polio recombinants

Principal Investigator: Matthias Gromeier, MD

Institute: Duke University

Initiative: Unrestricted Grant

Location: Durham, NC

Molecularly Guided Clinical Trials for Glioma

Principal Investigator: Paul Mischel, MD

Institute: University of California, Los Angeles

Initiative: Unrestricted Grant

Location: Los Angeles, CA

Monoclonal antibodies reactive with the angiostatin receptor to replace angiostatin as an anti-tumor agent

Principal Investigator: Carol J. Wikstrand, PhD

Institute: Duke University Medical Center

Initiative: Unrestricted Grant

Location: Durham, NC

Neural stem cells as a novel platform for gene therapy against brain tumors

Principal Investigator: Evan Y. Snyder, MD, PhD

Institute: Children’s Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Neuropsychological and Quality of Life late effects Study for the Treatment of Medulloblastoma/PNET

Principal Investigator: Johnathan Finlay, MB, ChB and Stephen Sands, PsyD

Institute: New York University School of Medicine

Initiative: Unrestricted Grant

Location: Manhattan, NY

Nonpathogenic polio recombinants as therapy for brain tumors

Principal Investigator: Eckard Wimmer, PhD

Institute: SUNY Stony Brook

Initiative: Unrestricted Grant

Location: Stony Brook, NY

Novel Approaches to Angiogenesis Inhibition in Experimental Glioma

Principal Investigator: Myrna R. Rosenfeld, MD, PhD

Institute: Memorial Hospital for Cancer and Allied Diseases

Initiative: Unrestricted Grant

Location: Manhattan, NY

Novel Hedgehog Pathway Antagonists as Potential Medulloblastoma Therapeutics

Principal Investigator: James K. Chen, MD

Institute: Stanford University

Initiative: Unrestricted Grant

Location: Stanford, CA

Oncolytic adenoviruses against brain tumor stem cells: the role of autophagy

Principal Investigator: Juan Fueyo, MD

Institute: MD Anderson Cancer Center

Initiative: Unrestricted Grant

Location: Houston, TX

PARG regulation of Temozolomide-induced mitotic checkpoint activation

Principal Investigator: Robert W. Sobol, PhD

Institute: University of Pittsburgh

Initiative: Unrestricted Grant

Location: Pittsburgh, PA

Petrochemical Exposures and Brain Neoplasms

Principal Investigator: David Christiani, MD

Institute: Harvard School of Public Health

Initiative: Unrestricted Grant

Location: Boston, MA

Prevalence Study

Principal Investigator: Carol Kruchko

Institute: Central Brain Tumor Registry of the United States

Initiative: Unrestricted Grant

Location: Hinsdale, IL

Recruitment of stem/progenitor cells to brain tumor vasculature

Principal Investigator: David Scadden, MD

Institute: Harvard Medical School

Initiative: Unrestricted Grant

Location: Boston, MA

Regulation of brain tumor angiogenesis by g-protein coupled receptors

Principal Investigator: Calvin Kuo, MD, PhD

Institute: Stanford University

Initiative: Unrestricted Grant

Location: Stanford, CA

Rheb GTPase as chemotherapeutic target of farnesyl transferase inhibitors in brain cancer

Principal Investigator: Lawrence Quilliam, PhD

Institute: Indiana University School of Medicine

Initiative: Unrestricted Grant

Location: Indianapolis, IN

Role of a novel member of the ETS transcription factor/ oncogene family, ESE-1, in human brain tumors

Principal Investigator: Towia Libermann, PhD

Institute: Beth Israel Deaconess Medical Center

Initiative: Unrestricted Grant

Location: Boston, MA

Role of thrombospondin-1 methylation in glioblastoma multiforme

Principal Investigator: Jean-Pierre Issa, MD

Institute: Johns Hopkins Hospital

Initiative: Unrestricted Grant

Location: Baltimore, MD

Single cell molecular pathophysiology of medulloblastoma

Principal Investigator: Peter B. Crino, MD, PhD

Institute: University of Pennsylvania

Initiative: Unrestricted Grant

Location: Philadelphia, PA

Somatic Cell Gene Transfer to Model Medulloblastoma in Mice

Principal Investigator: Daniel W. Fults, MD

Institute: University of Utah School of Medicine

Initiative: Unrestricted Grant

Location: Salt Lake City, UT

STAT3 as therapeutic target for glioblastoma

Principal Investigator: Brent Cochran, PhD

Institute: Tufts University School of Medicine

Initiative: Unrestricted Grant

Location: Boston, MA

Structural and biophysical investigation of plexin and the semaphorin system, as receptor-ligand complex implicated in the progression of brain tumors

Principal Investigator: Dimitar Nikolov, PhD

Institute: Memorial Sloan-Kettering Cancer Center

Initiative: Unrestricted Grant

Location: Manhattan, NY

Structural mechanisms of receptor signaling in brain tumor angiogenesis

Principal Investigator: Xiaolin He, PhD

Institute: Northwestern University

Initiative: Unrestricted Grant

Location: Evanston, IL

t(11;22) in Recurrent Malignant Glioma Provides a Novel Therapeutic Target

Principal Investigator: Adrienne C. Scheck, PhD

Institute: Barrow Neurological Institute

Initiative: Unrestricted Grant

Location: Scottsdale, AZ

Targeted and Global Methylation Analysis of Epigenetic Events in the Progression of Oligodendrogliomas in Serial Biopsies

Principal Investigator: John A. Maguire, MD

Institute: Vancouver General Hospital

Initiative: Unrestricted Grant

Location: Vancouver, BC

Targeting, imaging and therapy of gliomas via expression of recombinant biotinylated receptors

Principal Investigator: Xandra O. Breakefield, PhD

Institute: Massachusetts General Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Targeting Stromal and Tumor Compartments in Glioblastomas

Principal Investigator: Rakesh K. Jain, PhD

Institute: Massachusetts General Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

The regulation of VEGF expression in brain tumors

Principal Investigator: Henry M Furneaux, PhD

Institute: Memorial Sloan-Kettering Cancer Center

Initiative: Unrestricted Grant

Location: Manhattan, NY

The role of met tyrosine kinase in the regulation of apoptosis in malignant gliomas

Principal Investigator: Hui-Kuo G. Shu, MD, PhD

Institute: University of Pennsylvania

Initiative: Unrestricted Grant

Location: Philadelphia, PA

The Role of NOTCH Cell Signaling and INK4A/ARF Deletion in the Transformation of Radial Glia to Ependymoma Cancer Stem Cells

Principal Investigator: Richard Gilbertson, MD, PhD

Institute: St. Jude Children’s Research Hospital

Initiative: Unrestricted Grant

Location: Memphis, TN

The role of protein kinase C in astrocytomas

Principal Investigator: I. Bernard Weinstein, MD

Institute: Columbia-Presbyterian Cancer Center

Initiative: Unrestricted Grant

Location: Manhattan, NY

The role of PTEN tumor suppressor in regulating neural stem cells and tumorigenesis

Principal Investigator: Xin Liu, MD, PhD

Institute: University of California, Los Angeles

Initiative: Unrestricted Grant

Location: Los Angeles, CA

The role of the fibrinolytic system in development of metastasis to the brain

Principal Investigator: George Perides, PhD

Institute: Beth Israel Deaconess Medical Center

Initiative: Unrestricted Grant

Location: Boston, MA

Tumor antigens recognized by T cells in malignant glioma

Principal Investigator: Chris D. Platsoucas, PhD

Institute: Temple University School of Medicine

Initiative: Unrestricted Grant

Location: Philadelphia, PA

Updating Prevalence and Conditional Survival Estimates for All Primary (Malignant and Non-Malignant) Brain Tumors in the United States

Principal Investigator: Bridget McCarthy, PhD

Institute: University of Illinois at Chicago

Initiative: Unrestricted Grant

Location: Chicago, IL

Use of Phosphoinositide Analogues to Enhance Chemosensitivity: A Novel Adjuvant Chemotherapeutic for Medulloblastoma

Principal Investigator: William C. Broaddus, MD, PhD

Institute: Virginia Commonwealth University

Initiative: The Andrew Christian Bryce Pediatric Grant for PNET Research

Location: Richmond, VA

Vascular delivery of an amplifying vector for brain tumor therapy; Targeting, Imaging and Therapy of Gliomas Via Expression of Recombinant Biotinylated Receptors

Principal Investigator: Xandra Breakefield, PhD

Institute: Massachusetts General Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Wingless Signaling in Medulloblastomas: A Murine Tumor Model

Principal Investigator: Charles Eberhart, MD, PhD

Institute: Johns Hopkins Hospital

Initiative: Unrestricted Grant

Location:Baltimore, MD

Anti-angiogenic gene therapy for brain tumors

Principal Investigator: Lynn Hlatky, PhD

Institute: Dana-Farber Cancer Institute

Initiative: Unrestricted Grant

Location: Boston, MA

Molecular mechanisms of cytoxicity following drug-induced DNA damage in glioma cell lines

Principal Investigator: Howard Fine, MD

Institute: National Cancer Institute

Initiative: Unrestricted Grant

Location: Bethesda, MD

A New Target For Immunotherapy of Glioma

Principal Investigator: Boris Minev

Institute: University of California, San Diego

Initiative: Unrestricted Grant

Location: La Jolla, CA

A novel biomarker for glioma stem cells and GBM

Principal Investigator: Kyuson Yun, PhD

Institute: The Jackson Laboratory

Initiative: Unrestricted Grant

Location: Bar Harbor, ME

Principal Investigator: Kyuson Yun, PhD

Institute: The Jackson Laboratory

Initiative: Unrestricted Grant

Location: Bar Harbor, ME

Share